Revvity Inc (NYSE:RVTY)
$ 112.03 -0.64 (-0.57%) Market Cap: 13.82 Bil Enterprise Value: 16.21 Bil PE Ratio: 92.82 PB Ratio: 1.76 GF Score: 84/100

PerkinElmer Inc at Cowen Health Care Conference Transcript

Mar 06, 2023 / 02:10PM GMT
Release Date Price: $128.49 (-2.17%)
Max Masucci
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

We have Max Krakowiak, CFO, PerkinElmer. Thank you to both of you for being here.

Just as a quick reminder, we made an out-of-consensus upgrade call on Perkin in early January. There have been 2 additional upgrade sense. Our view is that the company's recent acquisitions, particularly BioLegend and its forthcoming divestitures make the go-forward Perkin much different from the Legacy Perkin that many investors are familiar with. So with that said, our questions will be focused on the topics that we uncovered during our process of upgrading the stock.

So before we jump into some questions that are specific to the continuing operations, I just want to hit a few big picture questions.

Questions & Answers

Max Masucci
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Just latest expectations for when the planned business divestiture will close. Are there any risk factors that we should be aware of in terms of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot